Literature DB >> 26550334

Diffusion-weighted magnetic resonance imaging in predicting the radiosensitivity of cervical cancer.

Xiaolei Ni1, Yuanhe Tong1, Youping Xiao2, Jiang Liao2, Yunbing Chen2, Min Wang3.   

Abstract

This study investigates the application value of diffusion-weighted magnetic resonance imaging in predicting cervical cancer radiosensitivity. Twenty-five patients who were newly diagnosed as cervical cancer and accepted simple radiotherapy were included in this study. Before external irradiation, 20 GY and at the end of irradiation, routine 1.5 T MRI and diffusion-weighted magnetic resonance imaging scanning were carried. Apparent diffusion coefficient (ADC) value of primary tumor was measured. Its correlation with tumor regression rate was analyzed. ADC values of before irradiation, 20 GY and at the end of irradiation was (0.93 ± 0.14) × 10(-3) mm(2)/s, (1.25 ± 0.17) × 10(-3) mm(2)/s and (1.55 ± 0.13) × 10(-3) mm(2)/s, respectively. There were statistical significant differences (P< 0.01). D-value of ADC values between before and 20 GY external irradiation was (0.33 ± 0.16) mm(2)/s. The tumor volume before and at the end of external irradiation were (37.48 ± 26.83) cm(3) and (4.41 ± 3.72) cm(3) respectively, with tumor regression rate of before and after external irradiation of (0.86 ± 0.11). ADC values of before irradiation, 20 GY and at the end of irradiation did not correlate with tumor regression rate. D-value of ADC values between before and 20 GY external irradiation positively correlated with tumor regression rate (r = 0.423, P = 0.035). ADC value of cervical cancer increased after radiotherapy and early changes of ADC value was positively correlated with tumor regression rate, thus, ADC value could be used as a potential prediction factor for cervical cancer radiosensitivity.

Entities:  

Keywords:  Cervical cancer; apparent diffusion coefficient; diffusion-weighted magnetic resonance imaging; radiosensitivity

Year:  2015        PMID: 26550334      PMCID: PMC4613019     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  18 in total

1.  [Diffusion weighted imaging features of normal uterine cervix and cervical carcinoma].

Authors:  Yun Zhang; Bi-Ling Liang; Li Gao; Rui-Xin Ye; Jun Shen; Jing-Lian Zhong
Journal:  Ai Zheng       Date:  2007-05

2.  Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy.

Authors:  Kuei C Lee; Bradford A Moffat; Anne F Schott; Rachel Layman; Steven Ellingworth; Rebecca Juliar; Amjad P Khan; Mark Helvie; Charles R Meyer; Thomas L Chenevert; Alnawaz Rehemtulla; Brian D Ross
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

Review 3.  Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology.

Authors:  Daniel A Hamstra; Alnawaz Rehemtulla; Brian D Ross
Journal:  J Clin Oncol       Date:  2007-09-10       Impact factor: 44.544

4.  Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy.

Authors:  Rebecca J Theilmann; Rebecca Borders; Theodore P Trouard; Guowei Xia; Eric Outwater; James Ranger-Moore; Robert J Gillies; Alison Stopeck
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI.

Authors:  Dominique Jennings; B Nicholas Hatton; Jingyu Guo; Jean-Philippe Galons; Theodore P Trouard; Natarajan Raghunand; James Marshall; Robert J Gillies
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

7.  Discrimination of metastatic from hyperplastic pelvic lymph nodes in patients with cervical cancer by diffusion-weighted magnetic resonance imaging.

Authors:  Yun B Chen; Jiang Liao; Rong Xie; Gui L Chen; Gang Chen
Journal:  Abdom Imaging       Date:  2011-02

8.  Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI.

Authors:  Yael Mardor; Yiftach Roth; Aharon Ochershvilli; Roberto Spiegelmann; Thomas Tichler; Dianne Daniels; Stephan E Maier; Ouzi Nissim; Zvi Ram; Jacob Baram; Arie Orenstein; Raphael Pfeffer
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

9.  Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer.

Authors:  Vanessa N Harry; Scott I Semple; Fiona J Gilbert; David E Parkin
Journal:  Gynecol Oncol       Date:  2008-09-06       Impact factor: 5.482

10.  Magnetic Resonance Imaging and Spectroscopy: Application to Experimental Neuro-Oncology.

Authors:  Brian D Ross; Thomas L Chenevert; Boklye Kim; Oded Ben-Yoseph
Journal:  Q Magn Reson Biol Med       Date:  1994
View more
  4 in total

Review 1.  The value of advanced MRI techniques in the assessment of cervical cancer: a review.

Authors:  Evelyn Dappa; Tania Elger; Annette Hasenburg; Christoph Düber; Marco J Battista; Andreas M Hötker
Journal:  Insights Imaging       Date:  2017-08-21

2.  Diffusion-weighted MRI for predicting treatment response in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis.

Authors:  Min Kyoung Lee; Yangsean Choi; So-Lyung Jung
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

3.  Diagnostic value of diffusion-weighted magnetic resonance imaging for local and skull base recurrence of nasopharyngeal carcinoma after radiotherapy.

Authors:  Chen Wang; Lidong Liu; Shaolv Lai; Danke Su; Younan Liu; Guanqiao Jin; Xuna Zhu; Ningbin Luo
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

4.  Value of Diffusion-Weighted Magnetic Resonance Imaging Combined with miR-18a Level in Predicting Radiosensitivity of Cervical Cancer.

Authors:  Xinhua Bu; Ji Zhang; Fangzheng Tian; Xiulan Wang; Linyun Wu; Weizhong Tian
Journal:  Med Sci Monit       Date:  2018-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.